AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer

Summary

This clinical study is looking at a vaccine called AST-VAC2 in adult patients with advanced non-small cell lung cancer (NSCLC). The main aim of the study: If the dose can be given safely to patients, learn more about the potential side effects of the vaccine and how they can be managed and also what happens to AST-VAC2 inside the body.

Timeline

Start

2018-05-29

Primary completion

2022-08-08

Completion

2022-08-08

Drugs

Indications